Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
Read More
Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention
Press Release
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Press Release
GSK enters agreement to acquire RAPT Therapeutics
Press Release
Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
Press Release
